ESMA LIBRARY

The ESMA Library contains all ESMA documents. Please use the search and filter options to find specific documents.
50
DOCUMENTS

REFINE YOUR SEARCH

Sections

Type of document

Your filters
Speeches X Corporate Information X Press Releases X Procurement X Warnings and publications for investors X Innovation and Products X Securities and Markets Stakeholder Group X Technical Advice X Summary of Conclusions X Opinion X ONGOING Procedure X
Reset all filters
Date Ref. Title Section Type Download Info Summary Related Documents Translated versions
27/03/2014 2014/332 Structured Retail Products- Good practices for product governance arrangements , Opinion PDF
203.1 KB
Legal basis 1.    Regulation (EU) No 1095/2010 (ESMA Regulation)  sets out the European Securities and Markets Authority’s (ESMA) scope of action, tasks and powers which include “enhancing customer protection”, and “foster[ing] investor protection”.  2.    In order to continue delivering on this investor protection statutory objective, ESMA is issuing this opinion on certain aspects linked to the manufacturing and distribution of structured retail products (SRP). This opinion takes into account relevant work done in this field both at European and interna-tional level.  3.    This opinion is without prejudice to the requirements for the provision of investment services and activities established in the Markets in Financial Instruments Directive (MiFID)  and its implementing measures (notably, Directive 2006/73/EC), the regulatory developments arising from the MiFID review or existing product rules that may apply to SRPs.  4.    ESMA’s competence to deliver an opinion is based on Article 29(1) (a) of the ESMA Regulation. In accordance with Article 44(1) of the ESMA Regulation, the Board of Supervisors has adopted this opinion. Background 5.    In its July 2013 report on ‘Retailisation in the EU’ , ESMA highlighted that, from a consumer protec-tion perspective, retail investors may face difficulties in understanding the drivers of risks and returns of structured products. If retail investors do not properly understand the risk and reward profile of structured products, and if the products are not properly assessed against the risk appetite of retail investors, retail investors might be exposed to unexpected losses and this might lead to complaints, reputational risks for manufacturers and distributors, and a loss of confidence in the regulatory framework and, more broadly, in financial markets. 6.    In 2013, ESMA mapped the measures adopted in the EU Member States in relation to complex products in order to identify issues and to better understand the rationale behind national initiatives (by looking at similarities and differences in the various approaches, and reviewing how complexity has been treated in the different EU Members States). 7.    As a result, ESMA has developed a broad set of non-exhaustive examples of good practices, attached as Annex 1 hereto, illustrating arrangements that firms - taking into account the nature, scale and complexity of their business - could put in place to improve their ability to deliver on investor protection regarding, in particular, (i) the complexity of the SRPs they manufacture or distribute, (ii) the nature and range of the investment services and activities undertaken in the course of that business, and (iii) the type of investors they target. These good practices should also be a helpful tool for competent authorities in carrying out their supervisory action. Opinion 8.    ESMA considers that sound product governance arrangements are fundamental for investor protec-tion purposes, and can reduce the need for product intervention actions by competent authorities. 9.    ESMA considers that, when supervising firms manufacturing or distributing an SRP, competent authorities should promote, in their supervisory approaches, the examples of good practices for firms set out in Annex 1 hereto. 10.    Although the good practices set out in Annex 1 hereto focus on structured products sold to retail investors, ESMA considers that they may also be a relevant reference for other types of financial in-struments (such as asset-backed securities, or contingent convertible bonds), as well as when financial instruments are being sold to professional clients. 11.    The exposure to risk is an intrinsic feature of investment products. The good practices set out in Annex 1 refer to product governance arrangements and do not (and cannot) aim at removing investment risk from products.
04/02/2021 ESMA22-106-3107 Summary of Conclusions Board of supervisors-SMSG- 17 December 2020 , Summary of Conclusions PDF
119.06 KB
03/01/2019 ESMA22-106-1605 Summary of Conclusions BoS and SMSG meeting 8 November 2018 Summary of Conclusions PDF
255.71 KB
15/02/2017 ESMA22-247440098-122 Summary of Conclusions BoS SMSG meeting 10 November 2016 Summary of Conclusions PDF
137.19 KB
10/09/2019 ESMA22-106-1925 Summary of Conclusions Joint BoS and SMSG meeting 12 July 2019 , Summary of Conclusions PDF
95.54 KB
10/03/2020 ESMA22-106-2123 Summary of Conclusions Joint BoS and SMSG meeting 4 December 2019 , Summary of Conclusions PDF
95.58 KB
01/07/2016 2016/SMSG/015 Summary of Conclusions Joint BoS SMSG meeting 26 May 2016 Summary of Conclusions PDF
231.88 KB
16/01/2018 ESMA22-106-788 Summary of Conclusions Joint BoS SMSG meeting 8 November 2017 Summary of Conclusions PDF
143.39 KB
18/02/2016 2016/SMG/005 Summary of Conclusions Joint meeting 11/12/2015 Summary of Conclusions PDF
159.42 KB
11/02/2021 ESMA22-106-3123 Summary of conclusions SMSG 17 December 2020 Summary of Conclusions PDF
103.5 KB
31/03/2016 2016/SMSG/004 Summary of Conclusions SMSG meeting 03/02/2016 Summary of Conclusions PDF
208.58 KB
11/05/2016 2016/SMSG/012 Summary of Conclusions SMSG meeting 05/04/2016 Summary of Conclusions PDF
200.68 KB
15/02/2017 ESMA22-247440098-121 Summary of Conclusions SMSG meeting 10-11 November 2016 Summary of Conclusions PDF
267.71 KB
17/05/2019 ESMA22-106-1780 Summary of Conclusions SMSG meeting 11 April 2019 Summary of Conclusions PDF
196.44 KB
18/02/2016 2016/SMSG/004 Summary of Conclusions SMSG meeting 11/12/2015 Summary of Conclusions PDF
141.56 KB
25/05/2018 ESMA22-106-1019 Summary of Conclusions SMSG meeting 12 April 2018 Summary of Conclusions PDF
208.57 KB
10/09/2019 ESMA22-106-1926 Summary of Conclusions SMSG meeting 12 July 2019 Summary of Conclusions PDF
157.68 KB
14/11/2016 2016/SMSG/018 Summary of Conclusions SMSG meeting 21 September 2016 Summary of Conclusions PDF
204.87 KB
17/11/2017 ESMA22-106-475 Summary of Conclusions SMSG meeting 21 September 2017 Summary of Conclusions PDF
206.1 KB
01/07/2016 2016/SMSG/016 Summary of Conclusions SMSG meeting 26-27 May 2016 Summary of Conclusions PDF
210.12 KB